Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era

Gaetana Sterrantino, Lucia Santoro, Dario Bartolozzi, Michele Trotta, Mauro Zaccarelli

Research output: Contribution to journalArticle

Abstract

Objective: To analyze self-reported adherence to antiretroviral regimens containing ritonavir-boosted protease inhibitors, nonnucleoside reverse transcriptase inhibitors (NNRTI), raltegravir, and maraviroc. Methods: Overall, 372 consecutive subjects attending a reference center for HIV treatment in Florence, Italy, were enrolled in the study, from December 2010 to January 2012 (mean age 48 years). A self-report questionnaire was filled in. Patients were defined as "nonadherent" if reporting one of the following criteria:

Original languageEnglish
Pages (from-to)427-433
Number of pages7
JournalPatient Preference and Adherence
Volume6
DOIs
Publication statusPublished - 2012

Keywords

  • Boosted protease inhibitors
  • HIV
  • Nonnucleoside reverse-transcriptase inhibitors
  • Self-reported adherence
  • Single tablet regimen

ASJC Scopus subject areas

  • Social Sciences (miscellaneous)
  • Medicine (miscellaneous)
  • Health Policy
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Fingerprint Dive into the research topics of 'Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era'. Together they form a unique fingerprint.

  • Cite this